Source: Post Online Media

Dualsystems Biotech Ag: Bundeskartellamt prohibits Remondis and DSD merger

The Bundeskartellamt has prohibited the proposed acquisition by REMONDIS SEof all the shares in the dual system DSD Duales System Holding. Andreas Mundt, President of the Bundeskartellamt: "The proposed merger would have significa...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Paul Helbling's photo - CEO of Dualsystems Biotech

CEO

Paul Helbling

CEO Approval Rating

90/100